Business
COEGIN: Follicopeptide launch on track, with improved Q1 results and strong market positioning
COEGIN: Follicopeptide launch on track, with improved Q1 results and strong market positioning
About this update from Coegin Pharma Ab
Coegin Pharma advanced Follicopeptide launch preparations, improved operating results, and maintained a strong equity ratio, while focusing on international partnerships and cost efficiency. The company targets major growth in the hair growth and skin pigmentation markets.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.